InvestorsHub Logo
Followers 0
Posts 59
Boards Moderated 0
Alias Born 03/26/2013

Re: None

Thursday, 11/20/2014 9:52:06 PM

Thursday, November 20, 2014 9:52:06 PM

Post# of 48316
Let me say I am invested in both INO and ONCS. You do realize INO has completed a phase 2 study of their lead candidate VGX-3100 and are gearing up to begin phase 3 in early 2016 at the latest. They also have several phase 1 trials advancing forward as well as completed preclinical studies published in peer reviewed journals.